NEW YORK (GenomeWeb News) - Norwegian company Genpoint has merged with Swedish firm MBS, the companies said today in a joint release.
 
The companies market DNA-analysis instruments and reagents for clinical diagnostics that have been used for tuberculosis, staph infections, and sexually transmitted diseases.
 
Erik Hornes, Genpoint's CEO, said the combined companies will continue to work on bacterial infections and will also shift to viral infections and cancer.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.